News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Talecris Biotherapeutics Files for $1 Billion IPO
July 30, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, July 27 (Reuters) - Biopharmaceutical firm Talecris Biotherapeutics Holdings Corp. said on Friday it is planning a $1 billion initial public offering of common stock.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Rare diseases
Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset
August 12, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline
August 10, 2026
·
2 min read
·
Gabrielle Masson
Manufacturing
AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant
August 10, 2026
·
2 min read
·
Nick Paul Taylor
IPO
BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs
August 10, 2026
·
5 min read
·
Tristan Manalac
